Risk of cancer in patients with psoriasis on biological therapies: a systematic review. (Record no. 27381838)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01449 a2200433 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517163955.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201904s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1365-2133 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1111/bjd.15830 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Peleva, E |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20190409 |
245 00 - TITLE STATEMENT | |
Title | Risk of cancer in patients with psoriasis on biological therapies: a systematic review. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The British journal of dermatology |
Date of publication, distribution, etc. | 01 2018 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 103-113 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Meta-Analysis; Systematic Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adalimumab |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biological Products |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dermatologic Agents |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Epidemiologic Methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Etanercept |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Infliximab |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasms |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Psoriasis |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Risk Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ustekinumab |
General subdivision | adverse effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Exton, L S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kelley, K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kleyn, C E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mason, K J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Smith, C H |
773 0# - HOST ITEM ENTRY | |
Title | The British journal of dermatology |
Related parts | vol. 178 |
-- | no. 1 |
-- | p. 103-113 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1111/bjd.15830">https://doi.org/10.1111/bjd.15830</a> |
Public note | Available from publisher's website |
No items available.